Could GLP-1 drugs help ward off a deadly disease? Cancer surgeon weighs in

Dr. Loren Rourke, a Texas-based board-certified breast cancer surgeon, author and speaker, confirmed research has suggested that glucagon-like peptide-1 medications may be associated with a lower risk of cancer recurrence.

Dr. Loren Rourke, a Texas-based board-certified breast cancer surgeon, author and speaker, confirmed research has suggested that glucagon-like peptide-1 medications — including Ozempic and Wegovy — may be associated with a lower risk of cancer recurrence and potentially new diagnoses.